80 related articles for article (PubMed ID: 21598032)
1. Disproportionate impact of combination antiretroviral therapy on AIDS incidence in Australia: results from a modified back-projection model.
Wand H; Falster K; Wilson D; Law M; Maher L
AIDS Behav; 2012 Feb; 16(2):360-7. PubMed ID: 21598032
[TBL] [Abstract][Full Text] [Related]
2. Increasing HIV diagnoses in Australia among men who have sex with men correlated with the growing number not taking antiretroviral therapy.
Murray JM; Prestage G; Grierson J; Middleton M; McDonald A
Sex Health; 2011 Sep; 8(3):304-10. PubMed ID: 21851769
[TBL] [Abstract][Full Text] [Related]
3. High rates of late HIV diagnosis among people who inject drugs compared to men who have sex with men and heterosexual men and women in Australia.
Wand H; Guy R; Law M; Wilson DP; Maher L
AIDS Behav; 2013 Jan; 17(1):235-41. PubMed ID: 22218722
[TBL] [Abstract][Full Text] [Related]
4. Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach.
Wand H; Yan P; Wilson D; McDonald A; Middleton M; Kaldor J; Law M
HIV Med; 2010 Jul; 11(6):395-403. PubMed ID: 20136660
[TBL] [Abstract][Full Text] [Related]
5. Trends in HIV/AIDS diagnoses among men who have sex with men--33 states, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(25):681-6. PubMed ID: 18583954
[TBL] [Abstract][Full Text] [Related]
6. HIV/AIDS among men who have sex with men and inject drugs--United States, 1985-1998.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jun; 49(21):465-70. PubMed ID: 10882293
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of combined antiretroviral therapy on multiple AIDS-defining illnesses in an HIV seroconverter cohort].
Ferreros I; Hurtado I; del Amo J; Muga R; del Romero J; García P; Alastrué I; Belda J; Guevara M; Pérez S;
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):179-84. PubMed ID: 21333403
[TBL] [Abstract][Full Text] [Related]
8. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
[TBL] [Abstract][Full Text] [Related]
9. Age and injecting drug use in Perth, Western Australia: the Australian national AIDS and injecting drug use study.
Loxley W; Marsh A; Lo SK
AIDS Care; 1991; 3(4):363-72. PubMed ID: 1786268
[TBL] [Abstract][Full Text] [Related]
10. HIV/AIDS among racial/ethnic minority men who have sex with men--United States, 1989-1998.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(1):4-11. PubMed ID: 10993566
[TBL] [Abstract][Full Text] [Related]
11. Differences in HIV disease progression by injecting drug use in HIV-infected persons in care.
Moore RD; Keruly JC; Chaisson RE
J Acquir Immune Defic Syndr; 2004 Jan; 35(1):46-51. PubMed ID: 14707791
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of HIV and AIDS in the United States.
Ward JW; Duchin JS
AIDS Clin Rev; 1997-1998; ():1-45. PubMed ID: 9305442
[TBL] [Abstract][Full Text] [Related]
13. Treatment for prevention of HIV transmission in a localised epidemic: the case for South Australia.
Heymer KJ; Wilson DP
Sex Health; 2011 Sep; 8(3):280-94. PubMed ID: 21851767
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of HIV-1 infection in Victoria. The Victorian Collaborative Group on HIV and AIDS Surveillance (VCGHAS).
Gertig D; Crofts N; Stevenson E; Breschkin A
Med J Aust; 1993 Jan; 158(1):17-20. PubMed ID: 8417284
[TBL] [Abstract][Full Text] [Related]
15. Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection.
Law MG; Li Y; McDonald AM; Cooper DA; Kaldor JM
AIDS; 2000 Jan; 14(2):197-201. PubMed ID: 10708291
[TBL] [Abstract][Full Text] [Related]
16. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
Vittinghoff E; Scheer S; O'Malley P; Colfax G; Holmberg SD; Buchbinder SP
J Infect Dis; 1999 Mar; 179(3):717-20. PubMed ID: 9952385
[TBL] [Abstract][Full Text] [Related]
17. HIV/AIDS behind bars.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1998 Apr; 4(4):8-13. PubMed ID: 11365184
[TBL] [Abstract][Full Text] [Related]
18. Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy.
Kowalska JD; Reekie J; Mocroft A; Reiss P; Ledergerber B; Gatell J; d'Arminio Monforte A; Phillips A; Lundgren JD; Kirk O;
AIDS; 2012 Jan; 26(3):315-23. PubMed ID: 22112597
[TBL] [Abstract][Full Text] [Related]
19. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
20. Estimation and prediction of the HIV-AIDS-epidemic under conditions of HAART using mixtures of incubation time distributions.
Heisterkamp SH; de Vries R; Sprenger HG; Hubben GA; Postma MJ
Stat Med; 2008 Mar; 27(6):781-94. PubMed ID: 17597471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
